CoChat

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses

Open access

Abstract

Rationale: Diverse autoantibodies are present in most patients with idiopathic pulmonary fibrosis (IPF). We hypothesized that specific autoantibodies may associate with IPF manifestations. Objectives: To identify clinically relevant, antigen-specific immune responses in patients with IPF. Methods: Autoantibodies were detected by immunoblots and ELISA. Intrapulmonary immune processes were evaluated by immunohistochemistry. Anti–heat shock protein 70 (HSP70) IgG was isolated from plasma by immunoaffinity. Flow cytometry was used for leukocyte functional studies. Measurements and Main Results: HSP70 was identified as a potential IPF autoantigen in discovery assays. Anti-HSP70 IgG autoantibodies were detected by immunoblots in 3% of 60 control subjects versus 25% of a cross-sectional IPF cohort (n = 122) (P = 0.0004), one-half the patients with IPF who died (P = 0.008), and 70% of those with acute exacerbations (P = 0.0005). Anti-HSP70 autoantibodies in patients with IPF were significantly associated with HLA allele biases, greater subsequent FVC reductions (P = 0.0004), and lesser 1-year survival (40 ± 10% vs. 80 ± 5%; hazard ratio = 4.2; 95% confidence interval, 2.0–8.6; P < 0.0001). HSP70 protein, antigen–antibody complexes, and complement were prevalent in IPF lungs. HSP70 protein was an autoantigen for IPF CD4 T cells, inducing lymphocyte proliferation (P = 0.004) and IL-4 production (P = 0.01). IPF anti-HSP70 autoantibodies activated monocytes (P = 0.009) and increased monocyte IL-8 production (P = 0.049). ELISA confirmed the association between anti-HSP70 autoreactivity and IPF outcome. Anti-HSP70 autoantibodies were also found in patients with other interstitial lung diseases but were not associated with their clinical progression. Conclusions: Patients with IPF with anti-HSP70 autoantibodies have more near-term lung function deterioration and mortality. These findings suggest antigen-specific immunoassays could provide useful clinical information in individual patients with IPF and may have implications for understanding IPF progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201203-0506oc

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 1

  1. Xue, 2011, Decreased survival of idiopathic pulmonary fibrosis patients with heat shock protein 70 autoreactivity [abstract], Am J Respir Crit Care Med, 183, A4275

Cited by

See all 190

Metadata

Authors
Kahloon, R. A., Xue, J., Bhargava, A., Csizmadia, E., Otterbein, L., Kass, D. J., Bon, J., Soejima, M., Levesque, M. C., Lindell, K. O., Gibson, K. F., Kaminski, N., Banga, G., Oddis, C. V., Pilewski, J. M., Sciurba, F. C., Donahoe, M., Zhang, Y., & Duncan, S. R.
Affiliations
  • University of Pittsburgh (US)
  • Beth Israel Deaconess Medical Center (US)
Corresponding author
Duncan, Steven R.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2013-04-01
Volume
187
Issue
7
Pages
768-775
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2142374046
Cited by
190
References
48
Citations by year
2026: 5 · 2025: 11 · 2024: 6 · 2023: 8 · 2022: 13 · 2021: 13 · 2020: 14 · 2019: 17 · 2018: 22 · 2017: 19 · 2016: 12 · 2015: 16 · 2014: 16 · 2013: 18
FWCI
12.89
Type
journal article
Language
en
Open access
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5p50hl084932-05, UL1TR000005, HL084948)
  • National Heart, Lung, and Blood Institute (K08HL083085, HL084948, HL007563, HL084932, P50-HL-084932, P50HL107172, U01HL112711, P50HL084948, HL107172, HL112711, T32HL007563)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
Keywords
idiopathic pulmonary fibrosis, HSP70, autoantigens, prognosis, survival, lung function decline, acute exacerbation, CD4+ T cells, monocytes, interleukin-8, IL-4, complement system, interstitial lung disease, autoimmunity
MeSH terms
Aged, Antigen-Antibody Complex, Autoantibodies, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoglobulin G, Immunohistochemistry, Lung, Male, Prognosis, Interleukin-4, Linear Models, Proportional Hazards Models, Interleukin-8, HSP70 Heat-Shock Proteins, Idiopathic Pulmonary Fibrosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses. https://app.cochat.ai/papers/10.1164/rccm.201203-0506oc
The paper
Kahloon, R. A., Xue, J., Bhargava, A., Csizmadia, E., Otterbein, L., Kass, D. J., Bon, J., Soejima, M., Levesque, M. C., Lindell, K. O., Gibson, K. F., Kaminski, N., Banga, G., Oddis, C. V., Pilewski, J. M., Sciurba, F. C., Donahoe, M., Zhang, Y., & Duncan, S. R. (2013). Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201203-0506oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.